ArticleCancer diagnosis & prognosis

Outcomes of Liposomal Irinotecan With 5-FU and Leucovorin in Patients With Metastatic Pancreatic Cancer and Borderline Performance Status.

Chieh-Ying Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.